Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most aggressive brain tumor and has a poor prognosis and is poorly sensitive to radiotherapy or temozolomide (TMZ) chemotherapy. Therefore, identifying new biomarkers to predict therapeutic responses of GBM is urgently needed. By using The Cancer Genome Atlas (TC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Lee, Hsun-Hua, Lin, Che-Hsuan, Lin, Hui-Yu, Kuei, Chia-Hao, Zheng, Jing-Quan, Wang, Yuan-Hung, Lu, Long-Sheng, Lee, Fei-Peng, Hu, Chaur-Jong, Wu, Dean, Lin, Yuan-Feng
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016639/
https://ncbi.nlm.nih.gov/pubmed/31906036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados